Study of intragastric pH profile after 5 days pantoprazole 40 mg iv followed by oral esomeprazole 40 mg po or oral pantoprazole 40 mg po

Study identifier:D9612L00066

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Randomized, Open-Label, Comparative, Two-Treatment, Crossover Study of the 24-Hour Intragastric pH Profile After 5 Days of Once Daily Oral Administration of Either Esomeprazole 40 mg or Pantoprazole 40 mg Following Once Daily Infusion of Intravenous Pantoprazole 40 mg for 5 Days in Healthy Volunteer Subjects

Medical condition

Healthy

Phase

Phase 4

Healthy volunteers

Yes

Study drug

-

Sex

All

Actual Enrollment

40

Study type

Interventional

Age

18 Years - 70 Years

Date

Study Start Date: 01 Sept 2004
Primary Completion Date: 01 Dec 2004
Study Completion Date: 01 Dec 2004

Study design

Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Other

Verification:

Verified 01 Jan 2015 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria